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The virulence mechanisms of the facultative intracellular parasite Rhodococcus equi remain largely unknown.
Among the candidate virulence factors of this pathogenic actinomycete is a secreted cholesterol oxidase, a
putative membrane-damaging toxin. We identified and characterized the gene encoding this enzyme, the choE
monocistron. Its protein product, ChoE, is homologous to other secreted cholesterol oxidases identified in
Brevibacterium sterolicum and Streptomyces spp. ChoE also exhibits significant similarities to putative choles-
terol oxidases encoded by Mycobacterium tuberculosis and Mycobacterium leprae. Genetic tools for use with R.
equi are poorly developed. Here we describe the first targeted mutagenesis system available for this bacterium.
It is based on a suicide plasmid, a selectable marker (the aacC4 apramycin resistance gene from Salmonella),
and homologous recombination. The choE allele was disrupted by insertion of the aacC4 gene, cloned in pUC19
and introduced by electroporation in R. equi. choE recombinants were isolated at frequencies between 1022 and
1023. Twelve percent of the recombinants were double-crossover choE mutants. The choE mutation was
associated with loss of cooperative (CAMP-like) hemolysis with sphingomyelinase-producing bacteria (Listeria
ivanovii). Functional complementation was achieved by expression of choE from pVK173-T, a pAL5000 deriv-
ative conferring hygromycin resistance. Our data demonstrate that ChoE is an important cytolytic factor for
R. equi. The highly efficient targeted mutagenesis procedure that we used to generate choE isogenic mutants will
be a valuable tool for the molecular analysis of R. equi virulence.
The nocardioform actinomycete Rhodococcus equi is a pri-
mary pathogen of horses. Rhodococcal infection occurs in
foals aged under 6 months old and results in severe pyogranu-
lomatous bronchopneumonia and a high mortality rate. Respi-
ratory disease is sometimes accompanied by mesenteric lymph-
adenitis and ulcerative enterocolitis. R. equi is widespread in its
natural habitat, the soil, and rhodococcal infection is endemic
in some horse farms. R. equi has recently emerged as an op-
portunistic pathogen in humans, especially in association with
human immunodeficiency virus infection. Like in foals, human
R. equi infection mainly affects the lungs, with clinical and
pathological characteristics similar to pulmonary tuberculosis
in immunocompromised patients. Although rare, granuloma-
tous pneumonia, lymphadenitis, and abscesses caused by R.
equi have been reported in a variety of mammals other than
horses and humans (11, 17, 32, 40).
Despite its importance in veterinary medicine and as an
emerging AIDS-associated pathogen, nothing is known about
the virulence mechanisms that R. equi uses to colonize host
tissues. The capacity of these bacteria to survive and to mul-
tiply inside the vacuolar compartment of macrophages is cen-
tral to rhodococcal pathogenesis (16). Virulence in the natural
host and in the mouse experimental model and the ability to
replicate in macrophages has been related to the presence of
an 80- to 90-kb plasmid (47). This plasmid is present in virtu-
ally all clinical isolates from foals, but it is absent from most
environmental strains (10, 14, 45). The plasmid carries a clus-
ter of seven vap genes encoding surface-associated proteins
which react in the form of 15- to 18-kDa antigens with sera
from pneumonic foals or from foals exposed to plasmid-con-
taining, virulent R. equi isolates (46, 47). Because Vap antigens
are upregulated at elevated temperatures (34 to 41°C) (46, 47)
and have a role in the protective immune response against R.
equi in foals (39), they are believed to play an important role in
pathogenesis. To date, only one attempt has been made to
assess the role of Vap proteins in virulence by using a genetic
approach. The vapA gene was expressed in a plasmid-cured
isogenic strain of R. equi, but this was not sufficient to restore
the capacity to proliferate in macrophages and to colonize the
lungs of experimentally infected foals (10), questioning a role
for VapA in virulence. The virulence plasmid itself does not
appear to be essential for pathogenesis in non-horse hosts, as
it is not always detected in clinical isolates from humans and
other animal species (4, 7, 33, 48, 49, 52). This suggests that
chromosomally determined factors are involved in R. equi
pathogenicity. Candidates for such chromosomal virulence fac-
tors include the following: the capsular polysaccharide, which
might interfere with phagocytosis; mycolic acid-containing gly-
colipids, which are thought to be involved in granuloma for-
mation; and, especially, cholesterol oxidase, a secreted enzyme
that may act on eukaryotic membranes and be responsible for
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the observed cytotoxicity and macrophage destruction that ac-
company rhodococcal infection (17, 40). However, as for
VapA, there is no direct proof that any of these putative
virulence factors are involved in pathogenesis.
A major reason why the molecular mechanisms of R. equi
pathogenesis remain unknown is the absence of genetic tools
for creating isogenic mutants affected in individual loci in these
bacteria. We have developed the first site-directed mutagenesis
system that is functional in R. equi. This system is based on
homologous recombination and on a suicide vector carrying a
cassette that confers apramycin resistance. This system allowed
us to generate cholesterol oxidase null mutants by insertional
disruption of the structural gene of the enzyme, choE, which
was also identified and characterized in this study.
MATERIALS AND METHODS
Bacteria, plasmids, and growth conditions. The bacterial strains and plasmids
used in this study are described in Table 1. R. equi and Escherichia coli were
routinely grown at 37°C in Luria-Bertani medium, with rotary agitation in the
case of fluid cultures. When required, antibiotics were added to culture media at
the following concentrations: apramycin, 30 mg/ml; hygromycin, 150 mg/ml; am-
picillin, 100 mg/ml.
DNA techniques. R. equi genomic DNA was prepared using a modification of
a previously described protocol (2). Bacteria from 5-ml aliquots of a stationary-
phase broth culture were collected by centrifugation at 10,000 3 g for 10 min,
washed in distilled water, resuspended in 0.25 ml of Tris-EDTA buffer containing
20 mg of lysozyme/ml and 50 mg of proteinase K/ml and incubated at 37°C for
2 h. Bacterial cells were then lysed by the addition of 0.25 ml of 0.1 M Tris
containing 1% sodium dodecyl sulfate (SDS) and 400 mg of proteinase K/ml and
incubated at 55°C for 1 h. The lysate was mixed with 0.1 ml of 5 M NaCl and 100
ml of cetyltrimethylammonium bromide-NaCl and incubated at 65°C for 10 min.
DNA was then extracted with choloroform-isoamyl alcohol and phenol-choloro-
form, precipitated with isopropanol, and resuspended gently in distilled water.
Plasmid DNA was extracted from E. coli using Qiagen plasmid purification kit.
Single-stranded DNA (ssDNA) was prepared by mixing 1 mg of plasmid DNA
with 20 ml of 0.2 M NaOH and 0.2 mM EDTA in distilled water. The mixture was
incubated at 37°C for 30 min and DNA was precipitated with ethanol according
to standard methodology. PCR products were purified from agarose gels with the
Qiaquick purification system (Qiagen). Restriction enzymes and ligase were
purchased from New England Biolabs and used according to the manufacturer’s
instructions. DNA was amplified using the Expand High-Fidelity PCR System
(Roche). For Southern blotting, restriction endonuclease-treated total DNA was
separated by agarose gel electrophoresis and immobilized on nylon membranes
(Roche) by capillary blotting. Radiolabeling was performed with [a-32P]dCTP
(Amersham) by random priming using the Ready-to-Go kit from Pharmacia.
Hybridization was performed at 65°C in 63 SSC (13 SSC is 0.15 M NaCl plus
0.015 M sodium citrate), 53 Denhardt’s solution, 0.5% SDS, and 20 mg of
salmon sperm DNA/ml. Blots were washed with 23 SSC, 0.5% SDS at room
temperature for 5 min and then with 23 SSC, 0.1% SDS at 37°C for 30 min.
DNA sequencing was performed on PCR products at the “Unidad de Secuen-
ciacio´n Automatizada de DNA” of the Universidad Complutense de Madrid
using an Applied Biosystems 377 apparatus. Homology searches were performed
with BLAST at the National Center for Biotechnology Information (Bethesda,
Md.) website and with the Pfam (protein family database) search tool on the
Sanger Centre (Cambridge, United Kingdom) internet server.
Electroporation of R. equi. Bacteria from 50 ml of a culture grown to an optical
density at 600 nm (OD600) of 0.6 were harvested by centrifugation, washed two
times in 25 ml of washing buffer (cold 10% glycerol in distilled water), and
resuspended in 0.2 ml of the same solution. Aliquots (40 ml) of the R. equi cell
suspension were mixed with 200 ng of DNA in a prechilled 0.2-cm chamber and
electroporated using the Gene Pulser apparatus (Bio-Rad) set at 2.5 kV/cm, 25
mF, and 1,000 V. After electroporation, the bacterial suspension was diluted with
1 ml of Luria-Bertani medium, incubated at 37°C for 2 h, and plated onto solid
medium containing the appropriate antibiotics.
RNA techniques. Total RNA was extracted from 50-ml broth cultures grown to
an OD600 of 0.6. Bacteria were harvested by centrifugation, resuspended in 2.5
ml of lysis buffer (0.02 M sodium acetate [pH 5.0], 1 mM EDTA, 20 mg of
lysozyme/ml), and transferred to a 100-ml Erlenmeyer flask. The bacterial sus-
pension was immediately frozen by placing the flask on dry ice and then thawed
at 37°C. This treatment was repeated five times. After the last thawing, 0.25 ml
of 10% SDS and 2.5 ml of 0.02 M sodium acetate-saturated phenol were added.
The mixture was incubated at 70°C for 5 min with shaking and spun for 5 min in
a microcentrifuge, and the aqueous phase was transferred to a fresh 100-ml flask.
Phenol extractions were repeated two more times. Aliquots of 0.4 ml of the final
aqueous phase were transferred to 2-ml microcentrifuge tubes, mixed with 40 ml
of sodium acetate (pH 7), and precipitated with 3 volumes of ethanol. The RNA
precipitate was collected by centrifugation at 12,000 3 g for 15 min at 4°C,
washed with 70% ethanol, and dried. The RNA pellet was resuspended in 100 ml
of diethyl pyrocarbonate-treated distilled water and stored at 270°C. Northern
blotting was carried out using 10 mg of RNA as previously described (12).
Cholesterol oxidase determinations. An assay based on the method described
by Sojo et al. (43) was used. Cultures were grown to an OD600 of 0.6. After
centrifugation, 0.1 ml of culture supernatant was mixed with 0.9 ml of reaction
buffer (50 mM potasium phosphate [pH 7.0], 5 mM sodium cholate, 7 mM
phenol, 0.4 mM 4-amino-antiprine, 1 mM cholesterol, 0.33% Triton X-100, and
6.7 U of horseradish peroxidase) and incubated at 37°C until a red color devel-
oped. Cholesterol oxidase activity units were calculated from the ratio between
A500 3 104 and A600 3 d 3 t, where d is the dilution factor and t is the reaction
time expressed in minutes. choE-derived cholesterol oxidase activity was calcu-
lated by subtracting the activity of the control (ChoE2) strain from that of the
isogenic test strain with functional choE allele.
Cooperative (CAMP-like) hemolysis assays. CAMP-like hemolysis tests were
performed on sheep blood agar plates with Columbia base medium (Difco) as
TABLE 1. Bacterial strains and plasmids
Bacterial strain
or plasmid Description
Source or
reference
R. equi
ATCC 6939 Type strain 30
MAD Cholesterol oxidase-
hyperproducing strain
42
1031 Clinical isolate with virulence
plasmid
8
1032 103 derivative lacking virulence
plasmid
8
RHE3-151 choE knockout mutant of 1031 This work
RHE3-19 choE knockout mutant of 1032 This work
L. ivanovii
ATCC 19119 Type strain Collection
E. coli
DH5a Cloning host strain Our laboratory
HB101 Cloning host strain Our laboratory
TG1 Cloning host strain Our laboratory
Plasmids
pUC19 Cloning vector 54
pGEM-Te T-vector for cloning of PCR
products
Promega
pPE207 E. coli-Mycobacterium shuttle
vector containing apramycin
resistance marker
37
pVK173-T E. coli-Mycobacterium shuttle
vector containing hygromycin
resistance marker
37
pRE7 E. coli-R. equi shuttle vector 55
pRHE1 pUC19 inserted with choE This work
pRHE2 pUC19 inserted with accC4 This work
pRHE3 pUC19 with choE::accC4 mutant
allele (suicide vector for choE
mutagenesis by gene
replacement)
This work
pRHE4 pGEM-Te inserted with choE
and its natural promoter
This work
pRHE5 pVK173-T inserted with choE
and its natural promoter
This work
pRHE6A pRE7 inserted with accC4 This work
VOL. 183, 2001 MUTAGENESIS OF RHODOCOCCUS EQUI CHOLESTEROL OXIDASE 4797
 o
n
 February 19, 2014 by guest
http://jb.asm.org/
D
ow
nloaded from
 
described previously (42). The test and indicator bacteria were streaked perpen-
dicularly to each other, leaving a distance between streaks of approximately 1
mm. Plates were incubated at 37°C overnight and the appearance of a shovel-
shaped patch of hemolysis at the intersection of the streaks (see Fig. 5), due to
the hemolytic cooperativity of the sphingomyelinase C produced by the indicator
strain (Listeria ivanovii) and the R. equi cholesterol oxidase (9, 42), was recorded
as a positive reaction.
Nucleotide sequence accession number. The sequence for the R. equi choE
gene has been deposited in the EMBL database under accession number
AJ242746.
RESULTS
Identification of the R. equi cholesterol oxidase gene choE. A
number of gram-positive bacteria with a high G1C content,
such as Brevibacterium sterolicum, Streptomyces spp., Mycobac-
terium spp., and Rhodococcus spp. (R. equi, R. erythropolis, and
R. rhodochrous), have a cholesterol oxidase activity (29). This
suggests that a common cholesterol oxidase genetic determi-
nant is widespread among actinomycetes and related bacteria.
Supporting this notion, the sequences of the cholesterol oxi-
dase genes cloned to date, choA and choM from two Strepto-
myces spp. isolates (5, 19) and choB from B. sterolicum (35),
show a high degree of similarity at both the nucleotide and
amino acid levels. To determine whether R. equi contains cho-
related sequences, Southern blots of genomic DNA digestions
from three strains of this species (1032, ATCC 6939, and
MAD) (Table 1) and 20 additional clinical isolates of human
and animal origin were probed with a choB DNA fragment.
Positive signals were obtained in a 2.3-kb PstI fragment for all
of the R. equi strains tested (data not shown). To isolate the
hybridizing R. equi DNA, a pair of degenerate oligonucleotide
primers {CoXN [59-AT(CT)TT(CT)TG(CT)GG(GC)ATGCT
(AGCT)AA(CT)CC-39] and CoXC [59-C(GT)(GC)GC(AG)A
A(CT)TT(AG)TACCA(CT)TC(AGCT)GT-39]} were de-
signed from the aligned amino acid sequences predicted from
the known cho genes and used in PCRs with genomic DNA
from strain 1032. A 0.3-kb DNA fragment was amplified,
cloned in pGEM-Te, and sequenced. The nucleotide sequence
obtained was 99% similar to that of the corresponding segment
of the choB gene. Several sets of primers were designed from
choB, which allowed us to assemble a 3.9-kb region of the R.
equi chromosome by direct and inverse PCR and subsequent
primer-walking sequencing (Fig. 1). The choB-related se-
quence in this region belonged to a 1,656-bp open reading
frame (ORF). The protein encoded by this ORF showed ex-
tensive similarity with the polypeptides encoded by the choles-
terol oxidase genes choB from B. sterolicum and choA and
choM from Streptomyces spp. (Fig. 2). It also exhibited signif-
icant similarity, albeit weaker, to polypeptides encoded by My-
cobacterium leprae, Mycobacterium tuberculosis, and Streptomy-
ces coelicolor described as probable cholesterol oxidases and
named as ChoD (Fig. 2). The R. equi ORF was designated
choE (for cholesterol oxidase of R. equi). choE was preceded at
the correct distance by a putative ribosome-binding sequence,
GAGG, and its stop codon was followed by a palindromic
sequence of 44 nucleotides that might act as a transcription
terminator. Putative 235 and 210 sites (GCGACG and CA-
GACC, respectively) were identified in the intergenic region
upstream from choE on the basis of known Rhodococcus pro-
moter sequences (1, 13, 23). The choE gene product, ChoE, is
552 amino acids long and has a predicted signal sequence of 45
residues (Fig. 2). A DNA fragment comprising the entire choE
gene plus its putative ribosome-binding sequence and the tran-
scription terminator was amplified by PCR with oligonucleo-
tide primers CoEN (59-TACCAAGCTTACCAAACCGCCGA
CAGAGGA-39) and CoEC (59-CAGTGAATTCCGCGTGAA
GAAAACGTGGTC-39) and inserted into pUC19, resulting in
pRHE1 (Table 1). E. coli TG1 cells transformed with pRHE1
produced cholesterol oxidase activity (Table 2) and displayed
cooperative, CAMP-like hemolysis with sphingomyelinase C-
producing bacteria (a marker of cholesterol oxidase produc-
tion; see below and Fig. 5). However, when TG1 was trans-
formed with pRHE3, in which choE is disrupted by an
antibiotic resistance cassette, neither cholesterol oxidase activ-
ity nor the CAMP-like hemolysis reaction was detected. These
results confirmed that choE encodes R. equi cholesterol oxi-
dase.
Genetic structure of the choE region and Northern blot
analysis of choE. Three additional ORFs coding for polypep-
tides similar to known protein sequences were identified in the
3.9-kb DNA fragment that contains choE (Fig. 1). Upstream
from choE, we found the 39 region of an ORF, cor (for cho-
lesterol oxidase region) U1, which encodes the last 159 resi-
dues of a protein with a high degree of similarity to a number
of bacterial 3-oxoacyl-(acyl carrier protein) reductases. These
enzymes belong to the short-chain dehydrogenase-reductase
superfamily that is widespread in bacteria, archaea, and eu-
FIG. 1. Genetic organization of the choE region and transcriptional analysis of choE. (A) Physical map of the 3.9-kb chromosomal region
encompassing the choE locus of R. equi. The location of the putative choE promoter and stem-loop transcription terminator is indicated. (B)
Northern blot analysis of choE in strains R. equi MAD (left) and 1032 (right). In both strains, a single 1.9-kb transcript was detected.
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karyotes. Immediately downstream from choE and transcribed
in the same orientation is corD1, which encodes a putative
homolog of the cfp30B gene product (67% identity), a 27.3-
kDa antigen from M. tuberculosis. The corD1 product (CorD1)
also shows a significant degree of similarity (32 to 39% iden-
tity) to polypeptides from Streptomyces and other actinomyce-
tes, which are annotated in the databases as “probable hydro-
lases” or “hypothetical proteins.” No obvious similarities were
detected between CorD1 and any known protein sequence of
archaeal or eukaryotic origin. Next to corD1, we found the 39
portion of a divergently transcribed ORF, corD2. Its product
shows significant similarity (26 to 35% identity) along most of
its sequence with hypothetical proteins from M. tuberculosis,
Streptomyces spp., and archaea, such as Aeropyrum, Pyrococcus,
and Sulfolobus.
Thus, the choE gene is encompassed by two ORFs, which
are transcribed in the same orientation (Fig. 1). In Streptomy-
ces spp. strain SA-COO, choA and the upstream gene, choP,
FIG. 2. Comparison of amino acid sequences of the cholesterol oxidases ChoE from R. equi (R. eq.; accession no. AJ242746) and ChoA from
Streptomyces spp. strain SA-COO (S. sp.; accession no. A32260), and related ChoD polypeptides from M. leprae (M. le.; accession no. S72824), M.
tuberculosis (M. tu.; accession no. F70736), and S. coelicolor (S. co.; accession no. AL161755). Identical amino acids are shaded in black and similar
amino acids are in gray. The putative cleavage site of the signal peptide of ChoE is indicated by an arrowhead.
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which encodes a cytochrome P-450-like protein, are cotrans-
cribed (18). To determine whether choE is expressed as part of
an operon with corU1 and/or corD1, total RNA from R. equi
strains 1032 and MAD was subjected to Northern blot analysis
using the entire choE gene as a probe (the CoEN-CoEC PCR
product). In both strains, a single ’1.9-kb transcript was de-
tected (Fig. 1). This is consistent with the expected size of the
choE message, indicating that choE is transcribed monocis-
tronically.
Construction of choE mutants. An important factor in the
development of a mutagenesis system is the availability of a
convenient marker for positive selection of recombinational
events. The following antibiotic resistance markers that had
been used for selection in rhodococci and related bacteria were
tested with R. equi: (i) the spectinomycin resistance gene,
aadA2, from the Corynebacterium glutamicum plasmid pCG4
(22); (ii) the kanamycin resistance gene from Tn903 (36)
present in the E. coli-R. equi shuttle vector pRE7 (55); (iii) the
apramycin resistance gene, aacC4, from the Salmonella en-
terica serovar Typhimurium plasmid Inc L/M (50), present in
the E. coli-Mycobacterium shuttle vector pPE207 (37); and (iv)
the chloramphenicol resistance gene from R. erythropolis plas-
mid pDA71 (41). Spectinomycin produced a high percentage
of spontaneous resistant mutants in 103 and other R. equi
strains and was discarded. In our hands, kanamycin, which was
previously reported to be useful for plasmid selection in R. equi
(55), also produced spontaneous mutants, although at a lower
frequency than spectinomycin. Apramycin and chlorampheni-
col at concentrations of 30 and 100 mg/ml, respectively, gave no
spontaneous resistant mutants, and the corresponding selec-
tion markers were further investigated. pRHE6A was con-
structed by cloning a NotI fragment containing the aacC4 gene
from pPE207 into the unique NotI site of pRE-7 (Table 1).
When electroporated into R. equi 1032 and 1031, apramycin-
resistant transformants (Aprr) appeared at a frequency of 1 3
106 and 1 3 105 per mg of DNA, respectively, which was
suitable for the development of a mutagenesis tool based on a
suicide vector. The chloramphenicol resistance gene from plas-
mid pDA71 was similarly tested but could not be expressed in
R. equi.
The identified choE locus was used as a target for mutagen-
esis by allelic exchange in R. equi. A pair of suicide plasmids,
pRHE2 and pRHE3, without and with choE target sequences,
respectively, was constructed for this purpose (Table 1 and Fig.
3). For pRHE2, a 1.6-kb PstI fragment from pPE207 contain-
ing the aacC4 apramycin resistance gene was inserted into the
corresponding restriction site of pUC19. For pRHE3, the
aacC4 gene was excised from pRHE2 and inserted into the
unique BamHI site of pRHE1, thus generating a recombino-
genic cassette comprising the aacC4 gene flanked by the 59 and
39 regions of choE (Fig. 3). The only origin of replication
present in pRHE2/3 was that from pUC19, which is nonfunc-
tional in R. equi. Thus, any Aprr colonies arising after electro-
poration of these plasmids into R. equi should result from
recombination of the plasmid with the genome of the host
bacterium. Strains 1032 and 1031 were electroporated with
200 ng of each of the plasmids and plated on solid medium
containing apramycin. No recombinants were detected with
pRHE2, but a large number of recombinants was obtained
with pRHE3. These data were compatible with the Aprr col-
onies resulting from site-specific chromosomal integration of
the suicide plasmid via homologous recombination between
choE sequences.
The use of ssDNA increased the number of Aprr recombi-
nants six-fold in both host strains. The number of recombi-
nants per microgram of DNA was 10-fold higher in strain 1032
than in 1031, consistent with the different transformation fre-
quencies observed with the bifunctional plasmid pRHE6A (see
above). Assuming that the suicide plasmids are taken up by R.
equi at a frequency similar to that of pRHE6A, the recombi-
nation efficiencies would be between 1 3 1022 and 1 3 1023
for pRHE3 and between ,1 3 1025 and ,1 3 1026 for
pRHE2 (Table 3).
To confirm that homologous recombination events were at
the origin of the Aprr phenotype in the pRHE3-transformed R.
equi, the structure of the choE region was analyzed by PCR
mapping and Southern blotting in 20 recombinants from each
of the R. equi strains, 1032 and 1031. For PCR mapping,
primers CoN (59-ACGCGTCCCGTCAGGCTCCGCT-39),
CoC (59-ACGCGTGAAGAAAACGTGGTCG-39), CoIN (59-
GTCAACAACATCGACCAGGCG-39), and CoP1 (59-GAC
GCTGAATACCGCGTCCT-39) were used. CoN and CoP1
target sequences were absent from the recombinogenic plas-
mid (Fig. 3). PCR amplifications with primers CoN and CoC,
which normally produce a 2.3-kb product in wild-type R. equi,
generated a 3.9-kb DNA fragment in three of the Apr recom-
binants analyzed from strain 1032 and two from the 1031
recombinants (Fig. 3 and 4). Similarly, a 1.6-kb increase in size
with respect to the parent strain was also observed when PCR
was performed in these recombinants with the primers CoIN
and CoP1. This is the expected size for a choE mutant allele
resulting from the integration of the aacC4 cassette by double-
crossover recombination (DCR) in the choE chromosomal lo-
cus (Fig. 3 and 4). The occurrence of a double recombination
event at the choE locus was verified by sequencing the junc-
tions between choE and the aacC4 cassette from two DCR
mutants, RH3-19 (from 1032) and RH3-151 (from 1031). The
other 35 Aprr transformants were single-crossover recombi-
nants (SCRs), resulting from the integration of pRHE3 either
via the upstream (SCR-1) or the downstream (SCR-2) choE
target sequences. Of these SCRs, 33 were of the SCR-1 type,
characterized by a larger CoN-CoC product of 3.9 kb (1.6-kb
increase in size) and a wild-type CoIN-CoP1 product of 1.6 kb,
with no PCR product being generated with primers CoN and
CoP1 (Fig. 3 and 4). Only two recombinants (both from strain
TABLE 2. ChoE activity determinations
Strain Enzyme activitya
E. coli
TG1(pUC19)........................................................................... 0
TG1(pRHE1)..........................................................................100.7
R. equi
1032 ......................................................................................... 29.5
RHE3-19 ................................................................................. 0
RHE3-19(pRHE5)................................................................. 37.3
1031 ......................................................................................... 32.3
RHE3-151 ............................................................................... 0
RHE3-151(pRHE5) .............................................................. 28.9
a choE-derived activity (see Materials and Methods).
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1031) were of the SCR-2 type, characterized by a CoN-CoC
product of wild-type size (2.3 kb) and a larger CoIN-CoP1
product of 3.2 kb (1.6-kb increase), with no product with CoN
and CoP1 (Fig. 3 and 4). Southern blot analyses of the inser-
tion mutants were entirely consistent with the results of PCR
mapping (Fig. 3 and 4).
Stability and phenotypic characterization of choE mutants.
To assess the stability of the choE insertion mutants, RHE3-19
and RHE3-151 were grown for approximately 100 generations
in the absence of selective pressure and plated out on antibi-
otic-free medium. One hundred colonies from each strain were
picked onto agar plates containing apramycin. All replica col-
onies grew in the presence of the antibiotic, indicating that the
aacC4 cassette was stably inserted into the R. equi chromo-
some.
TABLE 3. Recombination frequencies of the suicide
plasmid pRHE3 (containing choE target sequences) or pRHE2
(no choE target sequences) in R. equi
Suicide plasmid
Recombination frequencya in strain:
1031 1032
pRHE3 1.9 3 1023 7.5 3 1023
pRHE3ss 11.5 3 1023 47.5 3 1023
pRHE2 ,1025 ,1026
pRHE2ss ,1025 ,1026
a Recombination frequencies were calculated as the ratio between transfor-
mation frequencies (expressed as Aprr colonies per microgram of DNA) ob-
tained with the suicide plasmids and with the pRHE6A vector, which replicates
in R. equi.
FIG. 3. Schematic diagram of the procedure for targeted mutagenesis of choE by homologous recombination and a physical map of the choE
locus in the parent strain (WT) and the recombinants (SCR-1 and SCR-2, single crossover recombinants in sites 1 and 2, respectively, and DCR,
double crossover recombinant). The recombinogenic cassette in the suicide plasmid, pRHE3, includes the aacC4 apramycin resistance gene, shown
in black, surrounded by the flanking choE target sequences, shown in dark gray. The wild-type choE allele is light gray. The crossover target
sequences in each type of recombinant are dashed in light and dark gray. CoN-CoC and CoIN-CoP1 primer pairs were used for PCR mapping,
and M indicates the position of the MluI restriction sites used in Southern blot analysis of the recombinants (Fig. 4).
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Although R. equi is nonhemolytic on sheep blood agar, it
develops a strong patch of synergistic hemolysis if streaked in
the vicinity of sphingomyelinase C-producing bacteria, such as
L. ivanovii or Staphylococcus aureus (42). Cholesterol oxidase
is thought to be the R. equi factor responsible for this cooper-
ative, CAMP-like lytic reaction (9, 26, 42). The five DCRs, in
which only a disrupted choE allele is present on the chromo-
some, were negative in a CAMP-like hemolysis test with L.
ivanovii (Fig. 5). This correlated with a loss of cholesterol
oxidase activity in the culture supernatant of these mutants
(Table 2). All of the SCR mutants, which bear an intact copy
of choE in addition to the choE::aacC4 allele (Fig. 3), tested
positive in the CAMP-like reaction and produced cholesterol
oxidase activity at wild-type levels (data not shown). These
results were consistent with the involvement of cholesterol
oxidase in the cooperative hemolysis shown by R. equi with L.
ivanovii.
The choE mutation had no effects on colony morphology,
bacterial growth rate, or biochemical profiles.
Complementation of choE mutants. To confirm directly that
the disruption of choE was responsible for the observed loss of
CAMP-like reactivity, we complemented the DCR mutants
with choE. A DNA fragment containing choE plus its putative
promoter region was inserted into pVK173-T, a pAL5000 de-
rivative, giving rise to pRHE5 (Table 1). We previously verified
that pVK173-T replicates and can be selected via its hygromi-
cin resistance marker in R. equi. Introduction of pRHE5 re-
stored cholesterol oxidase activity (Table 2) and CAMP-like
reactivity with L. ivanovii (Fig. 5) in both RH3-19 and RH3-
151. These results were entirely consistent with those obtained
by complementation of E. coli with choE (see above) and
confirmed that cholesterol oxidase is the R. equi membrane-
damaging factor responsible for cooperative hemolysis with
sphingomyelinase C-producing bacteria.
Finally, we assessed the stability of pRHE5 in R. equi by
testing the number of bacteria that retained the hygromycin
resistance (Hygr) phenotype after growth for 100 generations
without selective pressure, as described above. The percentage
of Hygr colonies decreased from 90% after 20 generations to
6% after 60 generations. These data show that the pAL5000-
based mycobacterial replicon is largely unstable in the absence
of selective pressure in R. equi.
DISCUSSION
We approached the molecular analysis of R. equi virulence
by investigating cholesterol oxidase, a putative membrane-ac-
tive virulence factor that is released into the culture superna-
tant by all isolates of this pathogenic actinomycete. We iden-
tified the gene encoding this enzyme by PCR using degenerate
oligonucleotides designed from the known sequences of cho-
lesterol oxidase genes previously identified in several high-
G1C-content gram-positive bacteria. The R. equi cholesterol
oxidase gene, choE, was almost identical (99.2% identity) to
choB from B. sterolicum, and their corresponding protein prod-
ucts differed only in one residue. This high degree of sequence
FIG. 4. PCR mapping and Southern blot analysis of choE recombinants. (A) PCR mapping with CoN-CoC (upper panel) and CoIN-CoP1
(lower panel) primer pairs. See text and Fig. 3 legend for details. (B) Southern blot analysis. Genomic DNA from representative mutants of each
recombinational type were cut with MluI and hybridized against the CoEN-CoEC probe covering the entire choE gene. Hybridization patterns of
R. equi (WT), DCRs, and the two types of SCRs are shown. In R. equi, choE is flanked by two MluI sites separated by 2.3 kb; thus, the WT displays
a single 2.3-kb hybridization band. pRHE3 has a single MluI site located at the middle of the aacC4 gene (Fig. 3); therefore, DCR shows two bands
of 2.6 and 1.3 kb. In SCR-1, there were two bands of 2.6 and 5.7 kb. The 2.6-kb band is equivalent to the band of the same size observed in DCR
and corresponds to the left side of the aacC4-disrupted choE allele; the 5.7-kb band includes the right side of the aacC4-disrupted choE allele,
pUC19, and the intact copy of choE (Fig. 3). In SCR-2, two hybridization bands of 7.0 and 1.3 kb were observed (Fig. 3). When membranes were
rehybridized with a pUC19 probe, hybridization signals were detected in SCR-1 and SCR-2, confirming the presence of the complete pRHE3
plasmid integrated at the R. equi choE locus as the result of an SCR event (data not shown).
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conservation is unusual for two different bacteria, especially if
we take into consideration that the primary structures of the
cholesterol oxidases from two isolates belonging to the same
taxon (strains SA-COO and A19249 of Streptomyces spp.) are
20% divergent. The sequence identity between choE and choB
may be explained by a recent horizontal gene transfer event
between R. equi and B. sterolicum. Another possibility is that
ATCC 21387, the only known isolate of B. sterolicum (a species
which, in addition, is not officially recognized as belonging to
the genus Brevibacterium [21]), was missclassified and actually
belongs to R. equi. Morphological, physiological, and genetic
analyses on B. sterolicum ATCC 21387 suggest that this expla-
nation may be correct (our unpublished observations).
The 552-amino-acid-long ChoE protein has a putative signal
peptide of 45 residues and is similar (55 to 57% identity) to the
above-mentioned cholesterol oxidases from the Streptomyces
spp. strains SA-COO (19) and A19249 (5). These Streptomyces
cholesterol oxidases were originally designated ChoA and
ChoM (respectively) but now both are found in the protein
databases with the name ChoD. ChoE is also related, although
more distantly (24 to 27% identity), to a group of putative
polypeptides found in mycobacteria and in S. coelicolor (Fig.
2). These polypeptides are also designated ChoD in the protein
databases and are assumed to be cholesterol oxidases due to
their structural similarities with known cholesterol oxidase en-
zymes. However, unlike the cholesterol oxidases from R. equi
and Streptomyces spp. strains SA-COO and A19249, the myco-
bacterial and S. coelicolor ChoD proteins lack a signal se-
quence (Fig. 2), suggesting a cytoplasmic localization. This is
also the case for the hypothetical proteins Y4NJ from Rhizo-
bium sp. strain NGR234 (EMBL accession no. P55582) and
Rv0492c from M. tuberculosis strain H37RV, classified as pu-
tative glucose-methanol-choline (GMC)-type oxidoreductases
and which also exhibit significant similarity with ChoE (21 and
25% identity in a substantial sequence overlap, respectively).
Production of cholesterol oxidase has been reported in Myco-
bacterium spp. (44), and membrane-bound or cytoplasmic
forms of this enzymatic activity have been described in actino-
mycetes (20, 29). It remains to be determined whether the
more distant ChoD polypeptides from Mycobacterium and S.
coelicolor are indeed cytoplasmic cholesterol oxidases or en-
zymes without this activity but which belong to a group of
oxidoreductases that share general structural features with
cholesterol oxidases.
Targeted gene disruption via homologous recombination
provided experimental evidence that choE encodes a choles-
terol oxidase. Although there have been some previous at-
tempts to use this genetic strategy in rhodococci, as for exam-
ple in the plant pathogen Rhodococcus fascians (6) and in
various unclassified strains of biodegradative Rhodococcus spp.
(e.g., RHA1 and M5) (31, 53), this kind of mutagenesis pro-
cedure was not developed for R. equi. The previously described
mutagenesis procedures for non-R. equi rhodococci used as
selection markers the chloramphenicol resistance gene from R.
erythropolis or the kanamycin resistance gene from Tn903 (24).
However, in our hands these markers were unsuitable for R.
equi due either to the absence of expression (chloramphenicol)
or the appearance of an excessively high rate of spontaneous
resistance mutations (kanamycin).
We identified apramycin and the apramycin resistance gene,
aacC4, from the Salmonella plasmid IncL/M (50) as a clean
selection system for use in R. equi. This marker was previously
found to be useful in mycobacteria (37). With this selection
system, we constructed a suicide recombinogenic plasmid,
pRHE3, which allowed us to produce chromosomal choE in-
sertion mutants by allelic exchange following electroporation
in R. equi. Specific recombination at the choE locus was con-
firmed by PCR mapping, Southern blotting, and DNA se-
quencing. These recombination events were 10-fold more fre-
quently detected in R. equi 1032 than in 1031, possibly due to
the higher transformation efficiency of the former strain. The
reason for this higher transformability of 1032 is presently
unknown. As in other bacteria, such as Streptomyces (34) and
Mycobacterium (15), the frequency of homologous recombina-
tion increased if ssDNA was used for transformation. This
suggests that homologous recombination in R. equi proceeds
through the general recombinational pathway described for E.
coli, which involves a ssDNA intermediate (27). The use of
ssDNA may be useful to enhance the mutational efficiency in
R. equi strains more refractory to genetic manipulation than
strain 103.
The choE gene was targeted in all of the Aprr colonies
analyzed, and no Aprr transformants were obtained if the sui-
cide plasmid did not contain choE target sequences. This in-
dicates that homologous recombination works perfectly, and it
suggests that the frequency of illegitimate rearrangement is
negligible in R. equi. This is in contrast with the situation
described for other rhodococci, such as the biodegradative
Rhodococcus globerulus, in which most of the recombinants
obtained resulted from nonhomologous recombination (24).
The frequency of DCR we obtained (12% of the Aprr popu-
lation) was in the range of that reported in mycobacteria using
a similar mutational strategy (38). SCR-1-type recombinants
may have been obtained more frequently than SCR-2-type
recombinants because the choE target sequence upstream
from the aacC4 cassette in pRHE3 (1 kb) was significantly
longer than that situated downstream (0.6 kb).
Direct evidence that choE encodes a cholesterol oxidase was
obtained by trans-complementation in R. equi choE mutants as
FIG. 5. Cooperative hemolysis assays with the sphingomyelinase-
producing indicator species L. ivanovii (horizontal streaks). (A) Wild-
type R. equi 1032 (WT) and its isogenic derivatives RHE3-19 (choE/
pRHE5 mutant) and RHE3-19 (choE mutant choE). The choE mutant
has lost the capacity to produce a shovel-shaped CAMP-like reaction
and this property is recovered upon complementation with choE. (B)
E. coli K-12 with the control vector pRHE2 (vector) and with the
choE-containing plasmid pRHE1 (1choE); complementation with
choE confers CAMP-like activity similar to that of wild-type R. equi.
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well as in E. coli. A shuttle vector, pRE-7, containing the origin
of replication of the 80-kb virulence plasmid of R. equi and the
E. coli CoE1 ori from pBluescript, was available (55). Selection
with this plasmid was based on the aph kanamycin resistance
gene of pACYC177, originally from Tn903, which was shown
by us to be not suitable as it gives rise to spontaneous resistant
mutants at a relatively high frequency. Therefore, we tried
another shuttle vector, pVK173-T, containing an origin of rep-
lication derived from the mycobacterial plasmid pAL5000 and
a hygromycin resistance gene (10, 37). The choE-inserted
pVK173-T derivative (pRHE5) was able to replicate in R. equi
and complemented the choE mutation. However, in contrast to
pRE-7, which has been reported to be perfectly stable in R.
equi (55), the pAL5000-derived mycobacterial replicon was
unstable in R. equi in the absence of selective pressure.
In this study we have, finally, demonstrated that cholesterol
oxidase is a major membrane-damaging factor of R. equi. In-
activation of choE abrogated the rhodococcal cohemolytic ac-
tivity, which was restored upon complementation with choE. In
addition, the expression of choE in E. coli K-12 conferred to
this nonhemolytic bacterium the same membrane-damaging
activity as that of wild-type R. equi. This provides support to
the current belief that cholesterol oxidase is a major cytotoxic
factor possibly involved in macrophage and leukocyte destruc-
tion and in the generation of the pyonecrotic lesions that char-
acterize R. equi infection in humans and animals (26, 28, 40).
The membrane-damaging activity of R. equi is observed in vitro
on sheep blood agar as a cooperative, CAMP-like hemolytic
reaction in the presence of bacterial sphingomyelinase C (12,
42). This requirement for a concomitant exposure of erythro-
cytes to a sphingomyelinase indicates that the cholesterol ox-
idase substrate is not directly accessible to the enzyme in intact
membranes. Sphingomyelin is exposed on the outer lipid leaf-
let and its degradation by a sphingomyelinase leads to sublytic
damage of the membrane, allowing cholesterol oxidase to
reach its target substrate (9). The 3-hydroxyl of cholesterol,
thought to mediate sterol-phospholipid interaction, is thus ox-
idized, leading to the formation of cholest-4-en-3-one and the
total disorganization of the membrane (25). The relevance in
pathogenesis of this dependency of cholesterol oxidase on an-
other membrane-damaging enzyme for the exertion of a cyto-
lytic effect remains to be determined. In pathogenic bacteria
there are precedents for virulence factors that act coopera-
tively to cause membrane damage, as described for Listeria
hemolysin and phospholipases (51). There is evidence that R.
equi produces also a phospholipase activity (3), and it is pos-
sible that during infection this phospholipase forms part of a
bipartite cytolytic system together with ChoE to efficiently alter
the host cell membranes and cause cytotoxicity and tissue de-
struction. The choE isogenic mutants and the choE-comple-
mented bacteria described here will be instrumental in deter-
mining the role of ChoE in R. equi virulence.
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